Skip to content

Mobile Health for Alcohol Use Disorders in Clinical Practice

Integrating mHealth for Alcohol Use Disorders Into Clinical Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04011644
Enrollment
558
Registered
2019-07-08
Start date
2020-03-23
Completion date
2024-01-22
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Telemedicine

Keywords

implementation, alcohol drinking, mHealth, wellness

Brief summary

This study evaluates the impact on risky drinking days and quality of life for patients with alcohol use disorder among patients who use a mobile health smart phone application. A third of the participants will receive access to the smart phone app without any monitoring; a third of the participants will receive access to the smart phone app monitored by and connected with a peer mentor; a third will receive access to the smart phone app monitored by and connected with a health coach who works within a healthcare system.

Detailed description

Patients in the trial will be given versions of an evidence-based mobile-health (mHealth) system (re-design based on A-CHESS) that is delivered using different implementation strategies according to study group. A-CHESS has more than 18 services designed to improve social relatedness, coping competence, and intrinsic motivation. The following describes key A-CHESS services that will be tested in the current study: * Welcome message - patients write why they are choosing to reduce their drinking. * Coping with Cravings - the system automatically notifies nearby pre-approved friends, family, and peers, who can respond to a request for support. The patient can also be linked to positive activities, such as suggested games to download and play and audio/video-based relaxation recordings. * Monitoring functionality- self-assessment measures, record of A-CHESS use, and prediction of the patient's likelihood of having a heavy drinking episode in the next week. A-CHESS sends patients with worrisome responses suggestions of coping skills, online peer support, healthy events, etc. With patient permission, a prediction of high-risk can be shared with others in a position to provide support. * Triage and feedback functionality is designed to derail a setback in goal attainment, giving the patient 'just in time,' tailored support by linking patients to relevant A-CHESS resources or individuals (depending on group assignment). * The Specialist Report, harvests clinically relevant data from A-CHESS and presents it to a peer mentor (in the peer-supported group) or a health coach (in the clinically integrated group), at which point they may intervene with patients (e.g., through texting in A-CHESS). * Facilitated discussion groups (in the clinically integrated group.) Discussions are monitored daily by an A-CHESS coach. * Library - information about healthy lifestyle choices, calendar of healthy events in the area, etc. * Drink tracker and report feature - patients to self-monitor their drinking and each week see a summary of how they did the past week. * Profiles about why patients want to reduce their drinking. All patients enrolled in the study will participate in a 3-month intervention period followed by a 9-month follow-up period, for a total of 12 months. All patient will undergo a 72-hour run-in period. After 72 hours, patients who remain in the study will be randomized to one of the following groups and receive the appropriate access to features. One group will operate independently; one group will have help from a peer-mentor; one group will be connected to a healthcare system by a health coach.

Interventions

BEHAVIORALA-CHESS self-monitored

Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.

BEHAVIORALA-CHESS peer-supported

Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.

BEHAVIORALA-CHESS clinically-integrated

Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study will have rolling enrollment over two years. Patients will be enrolled and randomized to one of three interventions for 12 months.

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* are 21+ years old, * interested in learning about ways to reduce drinking, * willing to download and use A-CHESS, * lives in within the geographical boundaries of the UW Health system * be able to understand and sign an electronic consent form in English, * own an Apple or android smart phone, * meets the criteria for at risk drinking on the AUDIT screening, * responds yes to at least one question on the Alcohol Use Disorder (AUD) Diagnostic and Statistical Manual-5 survey, and * indicates in the past week they have had at least 7 drinks and 3 on a single day (women), or had at least 14 drinks and 4 on a single day (men).

Exclusion criteria

* has a severe alcohol use disorder (yes to 6+ items on the Alcohol Use Disorder (AUD) Diagnostic and Statistical Manual-5) * have a current psychotic disorder * have an acute medical problem requiring immediate hospitalization * have a known terminal illness

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Heavy Drinking Days, PHDD12 monthsPercentage of self-reported Heavy Drinking Days (HDD: 5 or more standard drinks on any day for men under 65, 4 or more standard drinks for women and men over 65) in the last 7 days
Quality of Life-Physical Health12 monthsThe physical health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-physical health (QoL-PH). It consists of 4 questions that assess overall physical health aspect of quality of life. Each question will ask patients to indicate their physical health on a scale of 1 (poor) to 5 (excellent). The raw scores of physical health scores (range: 0 to 20) are converted to T-scores (16.2 to 67.7). Higher scores mean better physical health aspects of quality of life.
Quality of Life-Mental Health12 monthsThe mental health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-mental health (QoL-MH). It consists of 4 questions that assess overall mental health aspect of quality of life. Each question will ask patients to indicate their mental health on a scale of 1 (poor) to 5 (excellent). The raw scores of mental health scores (range: 0 to 20) are converted to T-scores (21.2 to 67.6). Higher scores mean better mental health aspects of quality of life.

Secondary

MeasureTime frameDescription
Score of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool12 monthsThe Alcohol Use Disorders Identification Test (AUDIT) screening tool was used to assess patient alcohol severity. The screening tool consists of 10 questions with 5 possible answers (scoring 0-4). The sum scores of the 10 items are the scale scores ranging from 0 to 40. Higher scores indicate greater alcohol severity.
Score of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity12 monthsThe Diagnostic and Statistical Manual of Mental Disorders 5th edition criteria of alcohol use disorder will be used to assess the patient's alcohol use disorder severity. Each item has a score of 1 for agreement or 0 for disagreement of a statement. The sum score of all 11 items is the scale score (range of 0-11 - higher scores indicate greater severity). The severity of the AUD can also be defined as 1) mild: 2 to 3 symptoms; 2) moderate: 4 to 5 symptoms; 3) severe: 6+ symptoms.
Score of Relatedness as Assessed by the CHESS Bonding Scale12 monthsThe study will assess how connected patients feel with others. Greater connectedness is associated with fewer risky drinking days. Patients are asked five Likert-scale questions about their relationships with others, responding on a 1-5 scale from 'Never' to 'Nearly Always.' Mean scores are calculated as scale scores, ranging from 1 to 5. Higher scores indicate greater perceived relatedness with others.
Score of Competence as Assessed by the Perceived Competence Scale (PCS)12 monthsThe study will assess patients' perceptions of their ability to control and reduce their drinking in order to meet their alcohol use goals. Patients tend to drink less when they feel more confident in managing their alcohol use. Patients will respond to four questions from the Perceived Competence Scale (PCS) about their confidence in responsibly managing alcohol use in various situations. Responses are on a 1-7 scale, from 'Not at all' to 'Very true.' Mean scores (ranging from 1 to 7) are used as the scale scores, with higher scores indicating greater confidence in controlling or reducing drinking.
Score of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire12 monthsThe study assesses how motivated patients are by their own goals. Patients typically drink less when they, themselves, want to reduce their alcohol. Patients will be asked 6 questions from the autonomous motivation subscale of the Treatment Self-Regulation Questionnaire (TSRQ) about why they will reduce their alcohol use and can indicate how much they identify with each statement on a 1-5 scale corresponding to Not true to Very true, respectively. The mean scores are the scale scores, ranging from 1 to 5. Higher scores mean more autonomous motivation to control and reduce alcohol use.
Number of Patients Who Are Willing to Share Data12 monthsPatients in the clinically-integrated arm will have the option to share their data collected by A-CHESS with the health coach. Knowing how many patients are willing to share data about their drinking will allow researchers to make hypotheses about how effective A-CHESS can be in a healthcare setting. We did not collect data for this metric.
Number of Setback Status Triggered by A-CHESS12 monthsThe patient's ability to meet their weekly goal will be assessed. When patients are not on track to meet their weekly goal a setback alert will be triggered.
Variables Used for Predictive Setback Statusup to 3 yearsThe variables that help predict a setback will be assessed and reported. Knowing the variables for setbacks will help researchers program A-CHESS to better predict when patients are likely to have a setback.
Number of Response Statuses Addressedup to 3 yearsClinicians and patients will be alerted when the system predicts that they may have a setback. This allows researchers to know how useful patients and health coaches found the alerts.
Pages Viewed on A-CHESS12 MonthsThe number of pages viewed by patients and health coaches will be assessed know how useful patients found different content.
Number of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor12 monthsPatients will take a revised Brief Alcohol Monitor survey weekly that asks patients to indicate whether any of the five protection factors exist (sleep, mood, social interaction, work, and urges to drink). The protective factor score is the sum of the number of protection factor items reported by patients during the study period. The scores of the protective factors were planned to be used in the lapse prediction model. Since the study plan changes and the lapse prediction was not the focus of the study, only descriptive statistics are reported. No additional statistical analysis was conducted. Scores range from 7-35. Lower scores indicate a worse outcome for each factor.
Time of Tula Used12 monthsThe time that participants spent using Tula will be assessed.
Number of Hospital Nights in the Past 6 Months12 monthsPatients will be asked to indicate hospital stay (nights) in the past 6 months. Researchers will include this in the cost-effectiveness analysis.
Cost of Implementation of Each Intervention Arm in US Dollarsup to 3 yearsThe cost (in US dollars) of the intervention will be calculated to determine cost-effectiveness of the study.

Countries

United States

Participant flow

Recruitment details

A three-pronged recruitment strategy encompassing clinical settings, community-based organizations, and public media was used. Clinical study champions, including primary care providers, behavioral health specialists, etc., provided information to potentially eligible patients. Leaders from underrepresented communities promoted the study to their respective diverse populations. Lastly, targeted digital, television, and print media promoted the study broadly.

Pre-assignment details

The site staff were not enrolled in the clinical trial that is represented in the overall study flow diagram above and as such are not included in it. They were engaged in a post hoc interview to understand the study results for an exploratory analysis.

Participants by arm

ArmCount
Self Monitored
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., I will only drink on Friday this week.). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes. A-CHESS self-monitored: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a research team member. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
185
Peer Supported
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient. A-CHESS peer-supported: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a counselor. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
186
Clinically Integrated
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat. A-CHESS clinically-integrated: Patients have access to a smart phone app that provides information on tips on how to reduce drinking, a drink tracker, a journal, discussion boards, and private messaging with a health coach. Patients set weekly goals related to their drinking, reassess each week, and set a new goal for the upcoming week.
187
Total558

Baseline characteristics

CharacteristicClinically IntegratedTotalPeer SupportedSelf Monitored
Age, Continuous42.6 years
STANDARD_DEVIATION 12.9
42.8 years
STANDARD_DEVIATION 12.9
42.8 years
STANDARD_DEVIATION 12.9
42.80 years
STANDARD_DEVIATION 12.9
AUDIT Category
Alcohol dependence
62 Participants184 Participants61 Participants61 Participants
AUDIT Category
Harmful drinking
84 Participants241 Participants72 Participants85 Participants
AUDIT Category
Low risk
41 Participants133 Participants53 Participants39 Participants
Education
Bachelors
76 Participants235 Participants83 Participants76 Participants
Education
Doctorate
14 Participants47 Participants19 Participants14 Participants
Education
< High school
1 Participants3 Participants2 Participants0 Participants
Education
HS or GED
32 Participants67 Participants19 Participants16 Participants
Education
Masters
48 Participants121 Participants29 Participants44 Participants
Education
Vocation or associate
16 Participants85 Participants34 Participants35 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants14 Participants6 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
183 Participants544 Participants180 Participants181 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Percentage of heavy drinking days (PHDD)41.9 percentage
STANDARD_DEVIATION 31.4
38.4 percentage
STANDARD_DEVIATION 31.1
36.2 percentage
STANDARD_DEVIATION 31.2
37.1 percentage
STANDARD_DEVIATION 30.6
Quality of life-mental health, QOL-MH45.4 T-scores
STANDARD_DEVIATION 6.9
45.4 T-scores
STANDARD_DEVIATION 7.1
45.5 T-scores
STANDARD_DEVIATION 7.5
45.5 T-scores
STANDARD_DEVIATION 6.9
Quality of life-physical health, QOL-PH48.3 T-score
STANDARD_DEVIATION 6.5
48.3 T-score
STANDARD_DEVIATION 6.5
48.1 T-score
STANDARD_DEVIATION 6.7
48.4 T-score
STANDARD_DEVIATION 6.3
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants3 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
4 Participants11 Participants2 Participants5 Participants
Race (NIH/OMB)
Black or African American
10 Participants25 Participants8 Participants7 Participants
Race (NIH/OMB)
More than one race
1 Participants4 Participants3 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants2 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants6 Participants4 Participants1 Participants
Race (NIH/OMB)
White
170 Participants507 Participants167 Participants170 Participants
Sex: Female, Male
Female
123 Participants365 Participants122 Participants120 Participants
Sex: Female, Male
Male
64 Participants193 Participants64 Participants65 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 1850 / 1860 / 187
other
Total, other adverse events
0 / 1850 / 1860 / 187
serious
Total, serious adverse events
0 / 1850 / 1860 / 187

Outcome results

Primary

Percentage of Heavy Drinking Days, PHDD

Percentage of self-reported Heavy Drinking Days (HDD: 5 or more standard drinks on any day for men under 65, 4 or more standard drinks for women and men over 65) in the last 7 days

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredPercentage of Heavy Drinking Days, PHDD24.4 percentage of heavy drinking daysStandard Deviation 28.2
Peer SupportedPercentage of Heavy Drinking Days, PHDD21.4 percentage of heavy drinking daysStandard Deviation 28.9
Clinically IntegratedPercentage of Heavy Drinking Days, PHDD21.3 percentage of heavy drinking daysStandard Deviation 30.4
p-value: 0.688Mixed Models Analysis
Primary

Quality of Life-Mental Health

The mental health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-mental health (QoL-MH). It consists of 4 questions that assess overall mental health aspect of quality of life. Each question will ask patients to indicate their mental health on a scale of 1 (poor) to 5 (excellent). The raw scores of mental health scores (range: 0 to 20) are converted to T-scores (21.2 to 67.6). Higher scores mean better mental health aspects of quality of life.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredQuality of Life-Mental Health46.7439 T-ScoresStandard Deviation 8.25969
Peer SupportedQuality of Life-Mental Health47.6715 T-ScoresStandard Deviation 8.30113
Clinically IntegratedQuality of Life-Mental Health48.1160 T-ScoresStandard Deviation 7.03693
p-value: 0.014Mixed Models Analysis
Primary

Quality of Life-Physical Health

The physical health subscale of Patient Reported Outcomes Measurement Information System (PROMIS) Global-10 short form was used to assess the quality of life-physical health (QoL-PH). It consists of 4 questions that assess overall physical health aspect of quality of life. Each question will ask patients to indicate their physical health on a scale of 1 (poor) to 5 (excellent). The raw scores of physical health scores (range: 0 to 20) are converted to T-scores (16.2 to 67.7). Higher scores mean better physical health aspects of quality of life.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredQuality of Life-Physical Health48.5806 T-ScoresStandard Deviation 6.81051
Peer SupportedQuality of Life-Physical Health49.2869 T-ScoresStandard Deviation 6.44004
Clinically IntegratedQuality of Life-Physical Health48.1010 T-ScoresStandard Deviation 7.45609
p-value: 0.261Mixed Models Analysis
Secondary

Cost of Implementation of Each Intervention Arm in US Dollars

The cost (in US dollars) of the intervention will be calculated to determine cost-effectiveness of the study.

Time frame: up to 3 years

Population: Cost reflects total number enrolled, not number completed, to account for program being at full capacity.

ArmMeasureValue (NUMBER)
Self MonitoredCost of Implementation of Each Intervention Arm in US Dollars0 dollars
Peer SupportedCost of Implementation of Each Intervention Arm in US Dollars71750 dollars
Clinically IntegratedCost of Implementation of Each Intervention Arm in US Dollars124250 dollars
Secondary

Number of Hospital Nights in the Past 6 Months

Patients will be asked to indicate hospital stay (nights) in the past 6 months. Researchers will include this in the cost-effectiveness analysis.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredNumber of Hospital Nights in the Past 6 Months0.0534 Hospital nightsStandard Deviation 0.35762
Peer SupportedNumber of Hospital Nights in the Past 6 Months0.0469 Hospital nightsStandard Deviation 0.39404
Clinically IntegratedNumber of Hospital Nights in the Past 6 Months0.2178 Hospital nightsStandard Deviation 1.34613
Comparison: A univariate analysis (Analysis of Covariance or ANCOVA) was conducted to compare the number of hospital days among the three groups controlling for baseline assessment of the dependent variable and design factors (i.e., Sex and Severity).p-value: 0.908ANCOVA
Secondary

Number of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor

Patients will take a revised Brief Alcohol Monitor survey weekly that asks patients to indicate whether any of the five protection factors exist (sleep, mood, social interaction, work, and urges to drink). The protective factor score is the sum of the number of protection factor items reported by patients during the study period. The scores of the protective factors were planned to be used in the lapse prediction model. Since the study plan changes and the lapse prediction was not the focus of the study, only descriptive statistics are reported. No additional statistical analysis was conducted. Scores range from 7-35. Lower scores indicate a worse outcome for each factor.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredNumber of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor21.96 Score on a scaleStandard Deviation 5.45
Peer SupportedNumber of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor23.02 Score on a scaleStandard Deviation 5.25
Clinically IntegratedNumber of Patient Protection Factors Assessed by a Revised Brief Alcohol Monitor23.48 Score on a scaleStandard Deviation 5.63
Secondary

Number of Patients Who Are Willing to Share Data

Patients in the clinically-integrated arm will have the option to share their data collected by A-CHESS with the health coach. Knowing how many patients are willing to share data about their drinking will allow researchers to make hypotheses about how effective A-CHESS can be in a healthcare setting. We did not collect data for this metric.

Time frame: 12 months

Population: We did not collect data for this metric.

Secondary

Number of Response Statuses Addressed

Clinicians and patients will be alerted when the system predicts that they may have a setback. This allows researchers to know how useful patients and health coaches found the alerts.

Time frame: up to 3 years

Population: We did not implement this setback alert so no data are collected for this measure.

Secondary

Number of Setback Status Triggered by A-CHESS

The patient's ability to meet their weekly goal will be assessed. When patients are not on track to meet their weekly goal a setback alert will be triggered.

Time frame: 12 months

Population: We did not implement this setback alert so no data are collected for this measure.

Secondary

Pages Viewed on A-CHESS

The number of pages viewed by patients and health coaches will be assessed know how useful patients found different content.

Time frame: 12 Months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredPages Viewed on A-CHESS753.12 Page view countsStandard Deviation 517.05
Peer SupportedPages Viewed on A-CHESS891.84 Page view countsStandard Deviation 544.44
Clinically IntegratedPages Viewed on A-CHESS773.1 Page view countsStandard Deviation 458.18
p-value: 0.02Kruskal-Wallis
Secondary

Score of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool

The Alcohol Use Disorders Identification Test (AUDIT) screening tool was used to assess patient alcohol severity. The screening tool consists of 10 questions with 5 possible answers (scoring 0-4). The sum scores of the 10 items are the scale scores ranging from 0 to 40. Higher scores indicate greater alcohol severity.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredScore of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool9.0303 Scores on a scaleStandard Deviation 4.91289
Peer SupportedScore of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool9.3386 Scores on a scaleStandard Deviation 5.9271
Clinically IntegratedScore of Alcohol Use Disorders Identification Test (AUDIT) Screening Tool8.8283 Scores on a scaleStandard Deviation 5.54948
Comparison: A univariate analysis (Analysis of Covariance or ANCOVA) was conducted to compare the number of hospital days among the three groups controlling for baseline assessment of the dependent variable and design factors (i.e., Sex and Severity).p-value: 0.206ANCOVA
Secondary

Score of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire

The study assesses how motivated patients are by their own goals. Patients typically drink less when they, themselves, want to reduce their alcohol. Patients will be asked 6 questions from the autonomous motivation subscale of the Treatment Self-Regulation Questionnaire (TSRQ) about why they will reduce their alcohol use and can indicate how much they identify with each statement on a 1-5 scale corresponding to Not true to Very true, respectively. The mean scores are the scale scores, ranging from 1 to 5. Higher scores mean more autonomous motivation to control and reduce alcohol use.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredScore of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire3.8913 ScoresStandard Deviation 0.67081
Peer SupportedScore of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire3.9244 ScoresStandard Deviation 0.7311
Clinically IntegratedScore of Autonomous Motivation as Assessed by Revised Treatment Self Regulation Questionnaire4.0283 ScoresStandard Deviation 0.811
p-value: 0.555Mixed Models Analysis
Secondary

Score of Competence as Assessed by the Perceived Competence Scale (PCS)

The study will assess patients' perceptions of their ability to control and reduce their drinking in order to meet their alcohol use goals. Patients tend to drink less when they feel more confident in managing their alcohol use. Patients will respond to four questions from the Perceived Competence Scale (PCS) about their confidence in responsibly managing alcohol use in various situations. Responses are on a 1-7 scale, from 'Not at all' to 'Very true.' Mean scores (ranging from 1 to 7) are used as the scale scores, with higher scores indicating greater confidence in controlling or reducing drinking.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredScore of Competence as Assessed by the Perceived Competence Scale (PCS)5.1377 ScoresStandard Deviation 1.26652
Peer SupportedScore of Competence as Assessed by the Perceived Competence Scale (PCS)5.0788 ScoresStandard Deviation 1.34071
Clinically IntegratedScore of Competence as Assessed by the Perceived Competence Scale (PCS)5.39 ScoresStandard Deviation 1.50013
p-value: 0.025Mixed Models Analysis
Secondary

Score of Relatedness as Assessed by the CHESS Bonding Scale

The study will assess how connected patients feel with others. Greater connectedness is associated with fewer risky drinking days. Patients are asked five Likert-scale questions about their relationships with others, responding on a 1-5 scale from 'Never' to 'Nearly Always.' Mean scores are calculated as scale scores, ranging from 1 to 5. Higher scores indicate greater perceived relatedness with others.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredScore of Relatedness as Assessed by the CHESS Bonding Scale2.3022 ScoresStandard Deviation 0.85985
Peer SupportedScore of Relatedness as Assessed by the CHESS Bonding Scale2.7538 ScoresStandard Deviation 0.87037
Clinically IntegratedScore of Relatedness as Assessed by the CHESS Bonding Scale2.668 ScoresStandard Deviation 0.95525
p-value: <0.001Mixed Models Analysis
Secondary

Score of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity

The Diagnostic and Statistical Manual of Mental Disorders 5th edition criteria of alcohol use disorder will be used to assess the patient's alcohol use disorder severity. Each item has a score of 1 for agreement or 0 for disagreement of a statement. The sum score of all 11 items is the scale score (range of 0-11 - higher scores indicate greater severity). The severity of the AUD can also be defined as 1) mild: 2 to 3 symptoms; 2) moderate: 4 to 5 symptoms; 3) severe: 6+ symptoms.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredScore of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity2.5364 Scores on a scaleStandard Deviation 1.76447
Peer SupportedScore of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity2.5229 Scores on a scaleStandard Deviation 1.65326
Clinically IntegratedScore of the Diagnostic and Statistical Manual- 5 Alcohol Use Disorder (AUD) Severity2.9178 Scores on a scaleStandard Deviation 2.17763
Comparison: A univariate analysis (Analysis of Covariance or ANCOVA) was conducted to compare the number of hospital days among the three groups controlling for baseline assessment of the dependent variable and design factors (i.e., Sex and Severity).p-value: 0.104ANCOVA
Secondary

Time of Tula Used

The time that participants spent using Tula will be assessed.

Time frame: 12 months

ArmMeasureValue (MEAN)Dispersion
Self MonitoredTime of Tula Used17142.98 SecondsStandard Deviation 15043.75
Peer SupportedTime of Tula Used19851.64 SecondsStandard Deviation 16160.12
Clinically IntegratedTime of Tula Used17000.83 SecondsStandard Deviation 12961.23
p-value: 0.131Kruskal-Wallis
Secondary

Variables Used for Predictive Setback Status

The variables that help predict a setback will be assessed and reported. Knowing the variables for setbacks will help researchers program A-CHESS to better predict when patients are likely to have a setback.

Time frame: up to 3 years

Population: We did not implement this setback alert so no data are collected for this measure.

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026